sulpiride has been researched along with Cataleptic Attacks in 1 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okura, M | 1 |
| Riehl, J | 1 |
| Mignot, E | 1 |
| Nishino, S | 1 |
1 other study available for sulpiride and Cataleptic Attacks
| Article | Year |
|---|---|
Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
Topics: Animals; Arousal; Cataplexy; Dogs; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electroen | 2000 |